SHIKARI® Q-OMA


Enzyme immunoassay for the quantitative determination of Omalizumab (Xolair®) in serum and plasma.

Enzyme immunoassay for the quantitative determination of omalizumab (Xolair®) in serum and plasma. Matriks Biotek® omalizumab ELISA has been especially developed for the quantitative analysis omalizumab in serum and plasma samples between the Cmin and Cmax range of concentrations indicated in the pharmacokinetics section of prospectus..



Click the diagram to see bigger

about-me





Required Volume (µl) 5
Total Time (min) 70
Sample Serum, plasma
Sample Number 96
Dedection Limit (ng/mL) 0,01
Spike Recovery (%) 97
Shelf Life (year) 1

SHIKARI® S-ATO


Enzyme immunoassay for the qualitative determination (screening) of Omalizumab (Xolair®) in serum and plasma

The Matriks Biotek Antibody to omalizumab (Xolair®) Enzyme-Linked-ImmunoSorbentAssay (ELISA) Kit is intended for the qualitative determination of antibodies to omalizumab (Xolair®) in serum and plasma. It is for professional use only.






Required Volume (µl) 10
Total Time (min) 140
Sample Serum, plasma
Sample Number 96
Dedection Limit (ng/mL) + / -
Spike Recovery (%) -
Shelf Life (year) 1

MATRIKS BIOTECHNOLOGY CO., LTD

Gazi Üniversitesi Gölbaşı Yerleşkesi Teknoplaza Binası,
(B Blok Zemin Kat BZ17),
06830,
Gölbaşı/ANKARA/TÜRKİYE

Contact Details

Telephone: +90 (312) 485 42 94
Email: info@matriksbiotek.com
Fax: +90 (312) 485 11 87